68
Participants
Start Date
September 30, 2012
Primary Completion Date
July 31, 2013
Study Completion Date
January 31, 2014
Targinact® (oxycodone/naloxone)
University Hospital Brussels, Brussels
Lead Sponsor
Mundipharma CVA
OTHER